Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-pot synthesis of 3-cyanoindoles using copper catalysis. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel visible-light catalyzed method for 3-alkyl quinoxalin-2(1H)-ones. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering high yields and broad substrate tolerance for pharmaceutical manufacturing.
Novel palladium-catalyzed carbonylation route offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN116768904B reveals high-yield chiral synthesis for antitumor intermediates, offering significant cost reduction and enhanced supply reliability for global pharmaceutical manufacturing partners seeking scalable solutions.
Novel elemental sulfur-promoted method for high-purity triazole intermediates. Reduces cost and improves supply chain reliability for pharma manufacturing.
Patent CN115286578B reveals a metal-free route for trifluoromethyl pyrazole compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel iridium catalyzed asymmetric synthesis offers high enantioselectivity. Reduces costs and improves supply chain reliability for pharmaceutical intermediates globally.
Novel one-pot synthesis of quinone thiazole compounds. Reduces steps, eliminates toxic oxidants. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN108610304A reveals a novel Pd-catalyzed route for diarylsultams, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel biaryl ligand synthesis via Catellani reaction offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Novel heating-promoted synthesis of 2-trifluoromethyl quinoline. Metal-free, green chemistry, cost-effective for pharma intermediates. Reliable supply chain partner.
Patent CN115925527B details a Ru-catalyzed method for high-purity API intermediate synthesis, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN113307778A details a novel Mo-Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for reliable pharmaceutical intermediate suppliers.
Patent CN113121462A reveals a metal-free route for 5-trifluoromethyl-1,2,3-triazoles. This method offers cost reduction in pharmaceutical intermediate manufacturing via mild conditions.
Patent CN115286553B reveals nickel-catalyzed carbonylation for indole synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. Enhances purity and reduces toxic gas usage for API manufacturing.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering high yields and broad substrate tolerance for API intermediates.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Offers cost-effective, scalable routes for API intermediates without heavy metals.
Patent CN111410656B details a novel copper-catalyzed route to isoquinolinones, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production capabilities.